Cosmetic cross-reference

Sorbitan Monostearate

CAS 1338-41-6

Sorbitan Monostearate (CAS 1338-41-6) is a Phase 2 pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.

SOURCE NLM DailyMed

Label records

0

SOURCE EMBL-EBI ChEMBL

Bioactivity

1

SOURCE DrugCentral

Adverse signals

0

SOURCE IUPHAR/BPS

PubMed IDs

0

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Sorbitan Monostearate

CAS Number

1338-41-6

UNII

NVZ4I0H58X

InChIKey

HVUMOYIDDBPOLL-XWVZOOPGSA-N

ChEMBL ID

CHEMBL3186117

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

Synonyms and normalized names

SORBITAN STEARATE

natural product

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 2

Mid-stage clinical development phase from the compound identifier source.

ChEMBL CHEMBL3186117 | Small molecule

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE EMBL-EBI ChEMBL 1 bioactivity row

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

Target	Activity	Value	Assays	Organism
-	Potency	50118.7 nM	1	-

SOURCE NLM RxNorm 6 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
SORBITAN STEARATE	1363057	SU	MTHSPL
SORBITAN MONOSTEARATE	1363057	SU	MTHSPL
Sorbitan Monostearate	1363057	SU	MTHSPL
Sorbitan monostearate	1363057	SU	MTHSPL
sorbitan monostearate	1363057	SU	MTHSPL
sorbitan monostearate	1363057	IN	RXNORM

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Sorbitan Monostearate used for in pharmaceutical contexts?

Sorbitan Monostearate (CAS 1338-41-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Sorbitan Monostearate?

No adverse-event association or SIDER side-effect rows are rendered for Sorbitan Monostearate in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Sorbitan Monostearate also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Sorbitan Stearate with EU status "permitted".

What clinical phase is Sorbitan Monostearate in?

Sorbitan Monostearate is rendered with ChEMBL max phase 2.